Changes for page Neurodiagnoses
Last modified by manuelmenendez on 2025/03/03 22:46
From version 6.1
edited by manuelmenendez
on 2025/01/27 23:21
on 2025/01/27 23:21
Change comment:
There is no comment for this version
To version 8.1
edited by manuelmenendez
on 2025/01/27 23:22
on 2025/01/27 23:22
Change comment:
There is no comment for this version
Summary
-
Page properties (1 modified, 0 added, 0 removed)
Details
- Page properties
-
- Content
-
... ... @@ -2,8 +2,7 @@ 2 2 ((( 3 3 (% class="container" %) 4 4 ((( 5 -= **Neurodiagnoses** 6 -//A new tridimensional diagnostic framework for CNS conditions// = 5 += //A new tridimensional diagnostic framework for CNS conditions// = 7 7 8 8 This project is focused on developing a novel nosological and diagnostic framework for neurological diseases by using advanced AI techniques and integrating data from neuroimaging, biomarkers, and biomedical ontologies. 9 9 We aim to create a structured, interpretable, and scalable diagnostic tool. ... ... @@ -54,28 +54,11 @@ 54 54 * //Tests//: MRI volumetrics, FDG-PET, neuropsychological evaluations. 55 55 ))) 56 56 57 -==== **Case Studies** ==== 58 - 59 -1. ((( 60 -**Sporadic Alzheimer’s Disease**: 61 - 62 -* Axis 1: Sporadic (ApoE4, poor sleep habits). 63 -* Axis 2: Amyloid-beta plaques, elevated NFL. 64 -* Axis 3: Right hippocampus atrophy (visual memory loss). 65 -))) 66 -1. ((( 67 -**Genetic Parkinson’s Disease**: 68 - 69 -* Axis 1: Genetic (LRRK2 mutation). 70 -* Axis 2: Alpha-synuclein aggregation. 71 -* Axis 3: Substantia nigra degeneration (motor dysfunction). 72 -))) 73 - 74 74 ==== **Applications** ==== 75 75 76 76 This system enhances: 77 77 78 -* **Research**: By stratifying patients, itreduces cohort heterogeneity in clinical trials.60 +* **Research**: By stratifying patients, reduces cohort heterogeneity in clinical trials. 79 79 * **Clinical Practice**: Provides dynamic diagnostic annotations with timestamps for longitudinal tracking. 80 80 81 81 == Who has access? ==